×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Psoriasis Biosimilar Market

ID: MRFR/HC/35777-HCR
128 Pages
Rahul Gotadki
October 2025

Marktforschungsbericht zu Psoriasis-Biosimilars nach Biologikatyp (monoklonale Antikörper, Fusionsproteine, rekombinante Proteine), nach Verabreichungsweg (subkutan, intravenös, oral), nach Krankheitstyp (Plaque-Psoriasis, Psoriasis guttata, inverse Psoriasis, pustulöse Psoriasis), nach Vertriebskanal (Krankenhausapotheken, Einzelhandelsapotheken, Online-Apotheken) und nach Region (Nordamerika, Europa, Süden). Amerika, Asien-Pazifik, Naher Osten und Afrika) – Prognose bis 2034.

Teilen
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Psoriasis Biosimilar Market
 Infographic
Purchase Options

Psoriasis Biosimilar Market Zusammenfassung

Zu den wichtigsten Unternehmen im Psoriasis Biosimilar Market -Markt gehören

Berichtsumfang

Einen Kommentar hinterlassen

FAQs

What is the current valuation of the Psoriasis Biosimilar Market as of 2024?

The Psoriasis Biosimilar Market was valued at 4.211 USD Billion in 2024.

What is the projected market size for the Psoriasis Biosimilar Market by 2035?

The market is projected to reach 11.79 USD Billion by 2035.

What is the expected CAGR for the Psoriasis Biosimilar Market during the forecast period 2025 - 2035?

The expected CAGR for the market during 2025 - 2035 is 9.81%.

Which companies are considered key players in the Psoriasis Biosimilar Market?

Key players include Amgen, Sandoz, Mylan, Boehringer Ingelheim, Pfizer, Samsung Bioepis, Novartis, Teva, and Eisai.

What are the main segments of the Psoriasis Biosimilar Market?

The main segments include Biologics Type, Administration Route, Disease Type, and Distribution Channel.

How does the market for Monoclonal Antibodies compare to other biologics types?

The market for Monoclonal Antibodies was valued at 1.684 USD Billion in 2024 and is projected to grow to 4.67 USD Billion by 2035.

What is the projected market size for Plaque Psoriasis by 2035?

The market for Plaque Psoriasis is expected to grow from 2.1 USD Billion in 2024 to 5.8 USD Billion by 2035.

Which administration route is anticipated to have the highest market growth?

The Subcutaneous administration route, valued at 1.684 USD Billion in 2024, is projected to reach 4.67 USD Billion by 2035.

What distribution channel is expected to show significant growth in the Psoriasis Biosimilar Market?

Online Pharmacies, valued at 1.264 USD Billion in 2024, are expected to grow to 3.62 USD Billion by 2035.

How does the market for Guttate Psoriasis compare to other disease types?

The market for Guttate Psoriasis was valued at 0.9 USD Billion in 2024 and is projected to grow to 2.5 USD Billion by 2035.

Kostenloses Muster herunterladen

Bitte füllen Sie das folgende Formular aus, um ein kostenloses Muster dieses Berichts zu erhalten

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions